期刊文献+

老年患者胆红素及C反应蛋白水平变化与冠心病相关性分析 被引量:5

下载PDF
导出
摘要 目的:探讨老年患者总胆红素(TBIL)、间接胆红素(IBIL)、超敏C反应蛋白(hs-CRP)水平变化与冠心病发病及病情严重程度的相关性。方法:随机选取79例经冠状动脉造影检查明确冠心病的老年患者为观察组(冠心病组冠状动脉分支狭窄≥50%),据其病变严重程度分为单支、双支、多支病变组,及28例冠状动脉造影非冠心病老年患者为对照组(非冠心病组),回顾性分析不同组间TBIL、IBIL、hs-CRP水平变化,将其结果进行对比分析。结果:观察组TBIL、IBIL水平低于对照组,差异具有统计学意义(P<0.05),hs-CRP水平高于对照组,差异具有显著性(P<0.01);观察组内TBIL、IBIL水平随病变支数增加而降低,hs-CPR水平随病变支数增加而增加,差异均具有统计学意义(P<0.05)。结论:检测冠心病患者血清胆红素及hs-CRP水平,对于监测冠心病发病及评估冠心病严重程度有一定临床价值。
出处 《陕西医学杂志》 CAS 2013年第4期476-478,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献11

  • 1Yesilova Z, Serdar M , Ercin CN , et al. Decreased oxi- dation suscep tibility of plasma low density lipop roteins in patients with Gilberts syndrome [J ]. Gastroenterol Hepatol, 2008,23 (10) .. 1556-1560.
  • 2Bulmer AC, Blanchfield JT, Toth I, et al. Inproved re- sistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection [J]. Atheroscle- rosis, 2008,199 (2) 390-396.
  • 3刘娟,任洁,陈丽琴.超敏C反应蛋白与急性冠脉综合征的关系[J].现代医学,2009,37(1):14-15. 被引量:8
  • 4贾珠银,王军,季晓君.血清胆红素与冠心病的相关性研究[J].实用医学杂志,2005,21(24):2778-2779. 被引量:12
  • 5曹龙翔.胆红素D反应蛋白与冠心病关系的分析[J].河北医药,2009,15(2):202-204.
  • 6孙磊,顾翔,徐日新,何胜虎,李寿桢.冠心病患者超敏C反应蛋白的变化及临床意义[J].实用医学杂志,2005,21(17):1922-1923. 被引量:11
  • 7徐辉,蔡凯,李介华,夏明凯,黄超龙,张小勇,廖永华.超敏C反应蛋白与血脂联合分析在冠心病中的应用[J].广东医学,2005,26(12):1692-1694. 被引量:5
  • 8Ridker PM , Cushman M , Stampfer MJ, et al. Inflam mation, asp irin,and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997,3361 973- 979.
  • 9Onat A,Sansoy V,Yildiring B,et al. C-reactive protein in and coronary Heart disease in westem Turkey. An J Car- diol, 2001,88 601-607.
  • 10Backer JD , Mak R , Bacquer DD , et al. Parametetrs of inflammation And infection in a community based case- control study of coronary heart Disease. A therosclerosis, 2002,160:457-463.

二级参考文献24

  • 1林开敏,李卫华.炎症因子在冠心病事件中的临床价值[J].心血管病学进展,2007,28(1):81-84. 被引量:29
  • 2Pasceri V, Cheng J S, Willerson J T, et al. Modulation of C-reactive protein mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs [ J]. Circulation ,2001,103 ( 21 ) :2531-2534.
  • 3Arima H, Kubo M, Yonemoto K, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study [ J ]. Arterioscler Thromb Vasc Biol,2008,28 (7) : 1385-1391.
  • 4Luc G, Bard J M, Juhan-Vague I, et al. C-reactive protein, interleukin-6 and fibrinogen as predictors of coronary heart disease:the PRIME study [ J ]. Arterioscler Thromb Vasc Biol, 2003,23 (7) :1255-1261.
  • 5Danesh J, Wheeler J G, Hirschfield G M, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[ J]. N Engl J Med, 2004,350 (14) : 1387-1397.
  • 6Ross R. Atherosclerosis-an inflammatory disease. N EngL J Meal,1999,340(2): 115 - 126.
  • 7Ridler PM, Henekerrs CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N EngL J Med, 2000, 342(12):836 - 843.
  • 8Van Lente F. Markers of inflammation predictors in cardiovascular disease. Clin Chem Acta, 2000, 293( 1 - 2): 31 - 52.
  • 9Cerrnak J, Key Ns, Bach RR, et al. C-reactlve protein induce shuman peripheral blood monocytes to synthesize tissue factor. Blood,1993, 82(2): 513 - 520.
  • 10Biasucci LM. C-reactive protein and secondary prevention of coronary events. Clin Chem Acta, 2001, 311 ( 1 ): 49 - 52.

共引文献31

同被引文献53

  • 1向建军,吴碧胜.应用乐坦治疗冠心病伴糖尿病320例的心率变异观察[J].求医问药(下半月),2013(2):171-171. 被引量:1
  • 2饶大勇,许贤德.慢性心力衰竭患者血清总胆红素水平对预后判断的临床观察[J].中国心血管杂志,2006,11(5):378-379. 被引量:7
  • 3蒋博,刘宏斌.血红素加氧酶与动脉粥样硬化[J].中国组织工程研究与临床康复,2007,11(21):4221-4224. 被引量:3
  • 4葛均波,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:21.
  • 5ABRAHAM N G, KAPPAS A. Heme oxygenase and the cardiovascular-renal system[J]. Free Radic Biol Med, 2005, 39(1): 1 -25.
  • 6ERDOGAN D, GULLU H, YILDIRI M E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow- mediated vasodilation and increased carotid intima -media thickness in both men and women[ J]. Atherosclerosis, 2006, 184 (2) : 431 -437.
  • 7VERA T, GRANGER J P, STEC D E. Inhibition of bilirubin metabolism induces moderate hyperbilirub in emia and attenuates ANGII -dependent hypertension in mice[ J]. Am J Physiol Regul Integr Comp Physiol, 2009, 297 (3) : 738 - 743.
  • 8BHUIYAN A R, SRINIVASAN S R, CHENW, et al. Association of serum bilirubin with pulsatile arterial function in a symptomati- cyoung aduhs: the Bogalusa Heart Study[ J]. Metabolism, 2008, 57(5) : 612 -616.
  • 9PAPADAKIS J A, GANOTAKIS E S, JAGROOP I A, et al. Effect of hypertension and its treatmenton lipid, lipoprotein ( a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia [J]. Am J Hypertens, 1999, 12 (7) : 673 -681.
  • 10SCHWERTNER H A, JACKSON W G, TOLAN G. Association of low serum concentration of bilimbin with increased risk of coronary artery disease[ J ]. Clin Chem, 1994, 40 ( 1 ) : 18 - 23.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部